Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • onconaut
    Junior Member
    • Aug 2012
    • 7

    #1

    ERCC spike in controls for illumina?

    Hello Seqers,
    We have a illumina technician installing our HiSeq2000 as I write and I am trying to make some final improvements on my library constructions especially in the area of quality control.
    I saw that life tech has ERCC spike in controls pretty well incorporated into their protocols and pipeline. When I was looking for this in combination with illumina protocols I found nothing. When I called illumina tech support no one had ever heard of ERCC.

    Does anyone have experience with the ERCC controls?
    Do they really add that much more information in terms of helping helping me interpret my data?
    Why does illumina not use them/support them/know about them?

    Thanks a lot for your insights,
    O.
  • scbaker
    Shawn Baker
    • Aug 2008
    • 84

    #2
    Illumina does know about them, or at least they used to. Illumina participated in their creation (mostly in the form of me attending the meetings and helping to define the controls) . Life has probably done a better job at incorporating them because they are sold by Ambion (owned by Life).

    They can be as useful as you want them to be - they're just a set of artificial RNAs at known concentrations. Depending on when and where you spike them in, you can control for all sorts of variables.

    It's too bad Illumina hasn't done more - the probes are built into all of the expression arrays and they've done quite a bit of testing with the NGS assays, but I guess they don't have any official support. You might have better luck talking to someone in the bioinformatics department. They're the ones in R&D who spent the most time working on them and how best to do the analysis for NGS samples.

    Good luck!

    Comment

    • HESmith
      Senior Member
      • Oct 2009
      • 512

      #3
      A paper describing the use of ERCC controls for the Illumina platform can be found here.

      Comment

      • onconaut
        Junior Member
        • Aug 2012
        • 7

        #4
        This is extremely helpful. Thank you very much.

        Comment

        • bruce01
          Senior Member
          • Mar 2011
          • 160

          #5
          Wondering if anyone tried these spike-ins from pre-polyA capture? I am hoping to use them with total RNA as I am using Truseq v2 kits. My issue is quantification of RNA concentration. Obviously the nanodrop and bio are pretty 'variable', would the Qubit be precise enough? It would seem that not accurately quantifying concentration would lead to levels of spike-in which could cause issues with normalisation which the product is meant to be ameliorating...

          Comment

          • onconaut
            Junior Member
            • Aug 2012
            • 7

            #6
            Hello Bruce01,
            Ambion recommends to add the ERCC spikes prior to RNA selection. According to them it should also not make a difference whether you use poly-A selection vs. riboRNA depletion. However I have heard that poly-A selection introduces some bias as in that it does not capture all ERCC RNAs with the same efficacy. I have not done the experiment myself, nor have I seen the data, but that is one thing to keep in mind when you are doing your downstream analysis.
            We are using ERCC spikes-ins for all our library preps for now. Since we are working with archived RNA we have chosen riboRNA depletion over poly-A selection. We use Qbit for RNA quantification and have moved completely moved away from Nanodrop.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 11:13 AM
            0 responses
            19 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, Yesterday, 10:48 AM
            0 responses
            18 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            36 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            42 views
            0 reactions
            Last Post SEQadmin2  
            Working...